Levothyroxine sodium - Fresenius Kabi
Latest Information Update: 22 Jul 2015
At a glance
- Originator APP Pharmaceuticals
- Class Aromatic amino acids; Small molecules; Thyroid hormones
- Mechanism of Action Thyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypothyroidism
Most Recent Events
- 22 Jul 2015 The US FDA approved label for levothyroxine sodium for injection carries a black box warning